Skip to main content

Methyldopa Tablets Shortage

Last Updated: November 2, 2023
Status: Discontinued

Products Affected - Description
    • Methyldopa oral tablet, Accord, 250 mg, bottle, 100 count, NDC 16729-0030-01 - discontinued
    • Methyldopa oral tablet, Accord, 250 mg, bottle, 500 count, NDC 16729-0030-16 - discontinued
    • Methyldopa oral tablet, Accord, 500 mg, bottle, 100 count, NDC 16729-0031-01 - discontinued
    • Methyldopa oral tablet, Accord, 500 mg, bottle, 500 count, NDC 16729-0031-16 - discontinued
    • Methyldopa oral tablet, Mylan (Viatris), 250 mg, bottle, 100 count, NDC 00378-0611-01 - discontinued
    • Methyldopa oral tablet, Mylan (Viatris), 500 mg, bottle, 100 count, NDC 00378-0421-01 - discontinued
Reason for the Shortage
    • Accord has discontinued methyldopa.
    • Mylan discontinued the unit-dose presentations in 2019. They discontinued the 100 count bottles in June 2021.
    • Teva discontinued methyldopa tablets in 2018.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • All marketed presentations have been discontinued.

Updated

Updated November 2, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 28, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer